Ireland· IE-PA-EU/1/17/1194/001-008

Febuxostat Viatris 80 mg film-coated tablets

A febuxostat product containing febuxostat, registered in Ireland by Viatris Limited. The same ATC class is registered in 19 of our 19 countries.

ATC M04AA03

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about febuxostatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Febuxostat is registered in 19 of 19 countries.

Countries holding a registration under ATC M04AA03 (febuxostat), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
11 of them publish a price we can compare per daily dose

Search febuxostat products by name

Febuxostat · ATC M04AA03

19 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of febuxostat costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.34 in France to $1.89 in Switzerland — a ×5.6 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Febuxostat · price per daily dose (80 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.89
IT Italy$0.69
ES Spain$0.54
FR France$0.34

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Febuxostat
Manufacturer: Viatris Limited
Country: Ireland (IE)
ATC code: M04AA03
ATC class: Febuxostat
Defined daily dose: 80 mg, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
EU/1/17/1194/001-008

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for febuxostat.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check febuxostat against other medicines How interaction checks work

Febuxostat · interactions on record

25 records

6 severe
19 moderate

Most severe, free to view

MercaptopurineL01BB02severe
LeflunomidL04AA13severe
TeriflunomidL04AA31severe
LeflunomideL04AK01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Febuxostat in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All febuxostat products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Feburo, Febuxostat +pharma
Belgium · Feburik, Febuxostat Ab
Bulgaria · Адара, Адара 80 Mg Филмирани Таблетки
Cyprus · Febuxostat Genepharm, Urichofeb
Czechia · Febuxostat Sandoz
Germany · Febuxodor, Febuxostat 1 A Pharma
Denmark · Febuxostat Accord, Febuxostat Teva
Estonia · Druniler, Febuxostat Alembic
Spain · Febuxostat Aurovitas, Febuxostat Cinfa
Finland · Febuxostat Accord
France · Febuxostat Accord, Febuxostat Almus
United Kingdom (Northern Ireland) · Elstabya, Febuxostat
Greece · Buxodem, Febuxostat Genepharm
Croatia · Abuxar, Febuksostat
Hungary · Denofix, Doluric
Iceland · Adenuric, Febuxostat Krka
Italy · Alphabux, Arbux
Liechtenstein · Adenuric, Febuxostat Viatris
Lithuania · Druniler, Febuxostat Teva
Luxembourg · Feburik, Febuxostat
Latvia · Denofix, Druniler
Malta · Febuxostat Pharos
Netherlands · Feburik, Febuxostat Laboratorios Liconsa
Norway · Adenuric, Febuxostat Krka
Poland · Denofix, Febuxostat Aurovitas
Portugal · Bluesar, Febuxostate Aristo
Sweden · Feburo
Slovenia · Abuxar
Slovakia · Febuxostat Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e83862c4-73b3-448f-98e0-862678fbf7c1
GET /v1/drugs/e83862c4-73b3-448f-98e0-862678fbf7c1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "M04AA",
    "M04AA03"
  ],
  "strength": null,
  "pa_number": "EU/1/17/1194/001-008",
  "substances": [
    "Febuxostat"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "15/06/2017",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about febuxostat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console